PLEASANTON, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in products to treat cardiovascular disease, said today that it will be participating in the JP Morgan Healthcare Conference on Wednesday, January 9.
Gary Burbach, president and chief executive officer, will provide an update on the company, beginning at 8:30 a.m., Pacific Standard Time (11:30 a.m., Eastern Standard Time).
The presentation will be available through the conference website at http://www.metameetings.com/webcasts/jpmorgan/healthcare08 and on the company's website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's websites at http://www.thoratec.com or http://www.itcmed.com
|SOURCE Thoratec Corporation|
Copyright©2008 PR Newswire.
All rights reserved